Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches
Launched by SUPERPATCH LIMITED LLC · Jul 10, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Emerging technologies that use haptic (skin pressure) technology have been studied and have shown positive improvements in stress levels, balance, sleep, and pain. The FREEDOM and REM patch (SuperPatch Company, Toronto, Canada and Florida, USA) that also incorporates this technology has shown promise to improve relieve pain and improve sleep. This IRB-approved, Randomized Controlled Trial (RCT) will measure effectiveness of the pain and sleep patches through assessment of validated scales and functional measurements such as the Brief Pain Inventory (BPI), the Schober Test, the Bubble Inclin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 18-64
- • Ability to provide Informed Consent
- • Received a study patch (active or sham) from their treating clinician (randomized) for back, shoulder, and other musculoskeletal pain.
- • Has been diagnosed with an acute, moderate pain condition
- • Agrees to wear an adhesive study patch during the study period
- Exclusion Criteria:
- • Patients who are beneficiaries of a government-funded healthcare program
- • Use of drugs of abuse (illicit or prescription)
- • Have an implanted device, or wears, or adheres any electrical device to the body during the study, other than a hearing aid.
About Superpatch Limited Llc
Superpatch Limited LLC is an innovative clinical trial sponsor dedicated to advancing healthcare through the development of cutting-edge transdermal delivery systems. With a focus on creating effective and patient-friendly therapeutic solutions, Superpatch combines advanced technology with rigorous clinical research to enhance drug delivery methods. The company is committed to ensuring the highest standards of safety and efficacy in its trials, while fostering collaboration with healthcare professionals and regulatory bodies. Through its pioneering approach, Superpatch Limited LLC aims to improve patient outcomes and contribute to the future of medical treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tyrone, Georgia, United States
Patients applied
Trial Officials
Janet Fason, DO
Principal Investigator
Stein Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported